Form 4 for ROIV Roivant Sciences Ltd.

Accepted 2024-04-26 00:00:00 ET · period of report 2024-04-24 · accession 0001140361-24-022619 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
T	2024-04-26	2024-04-24	ROIV	MOMTAZEE JAMES C	Dir	A - Grant	$0.00	+1,490	77.8K	+2%	$0
T	2024-04-26	2024-04-24	ROIV	MOMTAZEE JAMES C	Dir	F - Tax	$10.90	-293	77.5K	-0.4%	-$3,194

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Shares	2024-04-24	A	A	1,490	$0.00	77,829	D	—	—	(F1) Reflects an award of restricted stock covering Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date. (F2) The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein and the filing of this statement shall not be deemed an admission that the reporting person is, for purposes of Section 16 or otherwise, the beneficial owner of any of the reported securities.
2	Common	Common Shares	2024-04-24	F	D	293	$10.90	77,536	D	—	—	(F3) Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares. (F2) The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein and the filing of this statement shall not be deemed an admission that the reporting person is, for purposes of Section 16 or otherwise, the beneficial owner of any of the reported securities.